Investigator in charge of the project: Dr.Antonio Pérez Martínez Centres: La Paz University Hospital, Madrid. Duration: Three years Financial target: €1,200,000   Background: Cancer is the main cause of childhood death in Spain.  Every year 1,400 children are diagnosed with cancer, of which 20% will die. This figure has remained unchanged for the last few decades.

    Activating a person’s immune response against cancer is one of the most exciting advances in cancer therapy   Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Normally our immune system fails to recognise cancer cells, as they can look like normal cells in our body and are

Lead Investigators: Dr. Luis Paz-Ares, Dr. Luis Álvarez-Vallina.   Centre: 12th October University Hospital, Madrid, Spanish National Cancer Research Centre (CNIO). Context: The concept of how cancer develops has changed radically over recent years. Tumours have ceased to be regarded as isolated bodies growing disconnected from their environment, and tumour cells have been shown to maintain

Main Researchers: –Prof Gareth J Morgan –Dr Lorenzo Melchor The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG United Kingdom Dr Joaquín Martínez López, Unidad de Hematología, I+12 Hospital 12 de Octubre  Dr Jesús San Miguel  Dr Bruno Paiva  Flow Cytometry Unit, Clinica Universidad de Navarra; Centro de Investigaciones Médicas Aplicadas (CIMA). Universidad de Navarra (Spain)  

Principal Investigators: Dr Alberto Ocaña, Dr Atanasio Pandiella Centres:  CHUA (University Hospital Complex of Albacete) – Albacete and CIC (Cancer Research Centre) – Salamanca Background Breast cancer is the most common type of cancer in women. It is estimated that one in ten women may suffer from it at some point in their lives. Although the great

CRIS is strongly committed to training medical and research personnel, with the goal of positioning itself as the global vanguard in cancer research and treatment.   In 2017, the CRIS Foundation financed 10 research fellowships, lasting between six months and one year, to allow Spanish researchers travel to centres of reference abroad and acquire expertise

El cáncer de ovario representa el sexto tumor más frecuente dentro de la población femenina en España. Tiene una mortalidad elevada, ya que no hay métodos de detección precoz y se suele diagnosticar cuando ya se encuentra diseminado.

Principal Researcher: Dr David Olmos and Dr Elena Castro. Centres: Spanish National Cancer Research Centre (CNIO), IBIMA (Biomedical Research Institute of Malaga). Background: Prostate cancer is the most common cancer in men in the western world and its incidence increases year on year. It already ranks third as a cause of male cancer death, after

Principal Investigator: Dr. Joaquín Martínez Centres: 12 de Octubre University Hospital, Madrid, Spanish National Cancer Research Centre (CNIO). Background: Haematological tumours, or blood cell tumours, are cancers that are currently largely incurable. They are the 4th most common group of tumours in Spain, with almost 30,000 new cases per year, of which only 50% are